MMP9 and lung cancer: Notably, the effect of ABL kinase inhibition on MMP9 secretion appears to be selective as secretion of amphiregulin (AREG), which is markedly enhanced by co-culture of MSCs with lung cancer cells, was not decreased by treatment with either GNF5 or ABL001 (Fig 4C and 4D).